Make Sure To Exercise On GLP-1 Meds (opens in new tab)

A new study by the "with obesity losing weight with glucagon-like peptide-1 (GLP-1) receptor agonist medications significantly decreased their physical activity, which is essential to protect muscle, according to a study being presented Saturday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill." "This is the first large study analyzing data from wearable fitness trackers among adults taking GLP-1 receptor agonists," they reported. Gizmodo, "Doctors at HSHS Saint John's Hos...